What do systematic reviews say?

Summary of findings: tobramycin for inhalation powder vs tobramycin

The review found no eligible studies for this question.

• Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Add‐on felbamate vs placebo

• Felbamate add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 64 participants
  Very low

Stiripentol vs add‐on placebo

The review found no eligible studies for this question.

• Stiripentol add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 45 participants
  Low

Sulthiame add‐on vs placebo

The review found no eligible studies for this question.

• Sulthiame add‐on therapy for epilepsy 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Ceftriaxone vs penicillin G

The review found no eligible studies for this question.

• Antibiotic therapy for adults with neurosyphilis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antidepressants vs placebo

• Adjuvant therapy with antidepressants for the management of inflammatory bowel disease 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 70 participants
  Low

Intervention not reported

• Enzyme replacement therapy for infantile‐onset Pompe disease 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 18 participants
  GRADE not reported

Interferon‐α alone vs interferon‐α plus bevacizumab

The review found no eligible studies for this question.

• Immunotherapy for metastatic renal cell carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Interferon‐α plus bevacizumab vs standard targeted therapies

The review found no eligible studies for this question.

• Immunotherapy for metastatic renal cell carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Vaccine treatment vs standard therapies

The review found no eligible studies for this question.

• Immunotherapy for metastatic renal cell carcinoma 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Therapeutic ultrasound vs placebo

• Electrotherapy modalities for rotator cuff disease 2016 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  Low

Intervention not reported

• Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Intervention not reported

The review found no eligible studies for this question.

• Positron emission tomography‐adapted therapy for first‐line treatment in individuals with Hodgkin lymphoma 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + estriol vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

GnRH‐a + ipriflavone vs GnRH‐a ± placebo

The review found no eligible studies for this question.

• Add‐back therapy with GnRH analogues for uterine fibroids 2015 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• The role of additional radiotherapy for primary central nervous system lymphoma 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Parenteral iron vs inactive control

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 1629 participants
  Very low

Parenteral iron vs oral iron

• Iron therapy in anaemic adults without chronic kidney disease 2014 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 771 participants
  Very low